Syneos Well being Appoints William E. Klitgaard Impartial Director

Syneos Well being Appoints William E. Klitgaard Impartial Director

Health Information Technology

Get instantaneous alerts when information breaks in your shares. Declare your 1-week free trial to StreetInsider Premium right here.

MORRISVILLE, N.C., Oct. 14, 2022 (GLOBE NEWSWIRE) — Syneos Well being® (Nasdaq: SYNH), the one totally built-in biopharmaceutical options group, right this moment introduced the appointment of William E. Klitgaard to its Board of Administrators. Mr. Klitgaard was beforehand a member of the Syneos Board from 2017 till Might 2022, having resigned as a result of a private matter. The Firm additionally introduced right this moment that Todd M. Abbrecht is stepping down from its Board of Administrators.

“We’re excited to welcome Invoice again to the Syneos Well being Board,” stated John Dineen, Chair of the Syneos Well being Board of Administrators. “Invoice’s deep monetary experience mixed together with his data of our firm are a welcome addition to an already robust Board, enhancing its composition. This appointment will assist continued profitable oversight of our technique as we velocity our clients’ supply of essential therapies to sufferers.”

Mr. Dineen added, “Syneos Well being has been effectively served by Todd’s contributions, and we thank him for his years of service to the Firm.”

Mr. Klitgaard will function a Class II director and as a member of the Firm’s Audit Committee. With these modifications, the Syneos Well being Board stays comprised of 10 administrators, 9 of whom are unbiased.

William E. KlitgaardMr. Klitgaard at the moment serves on the board of administrators of XIFIN, Inc., a well being info know-how firm and Avista Public Acquisition Corp. II, a particular objective acquisition firm, the place he serves because the Chair of the Audit Committee.

Mr. Klitgaard was an Working Govt at Avista Capital Companions, a non-public fairness agency targeted on healthcare from 2020 to 2021. He beforehand served because the President of Enlighten Well being, a division of LabCorp from 2015 to 2016. He additionally held varied roles over his 19-year profession at Covance, together with three years as Company Senior Vice President and Chief Info Officer, and practically twelve years as Company Senior Vice President and Chief Monetary Officer. He obtained his Bachelor of Arts in Economics from the College of California at Berkeley, and his Masters of Science from the Sloan Administration College on the Massachusetts Institute of Know-how.

About Syneos Well beingSyneos Well being® (Nasdaq: SYNH) is the one totally built-in biopharmaceutical options group purpose-built to speed up buyer success. We lead with a product improvement mindset, strategically integrating scientific improvement, medical affairs and industrial capabilities to deal with trendy market realities.

We deliver collectively greater than 29,000 minds, throughout greater than 110 nations, with a deep understanding of affected person and doctor behaviors and market dynamics. Collectively we share insights, use the newest applied sciences and apply superior enterprise practices to hurry our clients’ supply of essential therapies to sufferers.

Syneos Well being helps a various, equitable and inclusive tradition that cares for colleagues, clients, sufferers, communities and the atmosphere.

To study extra about how we’re Shortening the gap from lab to life®, go to or subscribe to our podcast.

Investor Relations Contact: Press/Media Contact:
Ronnie Speight Gary Gatyas
Senior Vice President, Investor Relations Govt Director, Exterior Communications
+1 919 745 2745 +1 908 763 3428
[email protected] [email protected]

Primary Logo

Supply: Syneos Well being, Inc.